Opportunity Information: Apply for CDC RFA GH13 1313
Apply for CDC RFA GH13 1313
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening Capacity for Laboratory Systems, Strategic Information, and Technical Leadership in Public Health for the National HIV/AIDS Response in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEP" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Feb 1, 2013 and posted on Jan 29, 2013.
- Applicants must submit their applications by Apr 15, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $20,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $4,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Among the PEPFAR priorities in Ethiopia supported by this Funding Opportunity Announcement is the strengthening of national capacity to collect and use HIV related surveillance systems, manage national HIV/AIDS programs by expanding HIV/STD/TB surveillance programs, and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring, and HIV screening for blood safety. EHNRI is the governmental agency with the mandate to support these public health activities, and is the only public health agency in Ethiopia with the mandate and authority to do so.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH13-1313) is a CDC-issued cooperative agreement under the PEPFAR program focused on Ethiopia, officially titled "Strengthening Capacity for Laboratory Systems, Strategic Information, and Technical Leadership in Public Health for the National HIV/AIDS Response in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR)." It was posted on January 29, 2013, with an application closing date of April 15, 2013, and it sits within the health activity category under CFDA 93.067 (Global AIDS). The CDC anticipated making one award through this announcement, with an estimated total funding amount of $20,000,000 and an award ceiling of $4,000,000. There was no cost sharing or matching requirement stated.
The central purpose of the opportunity is to strengthen Ethiopia's integrated public health laboratory systems and to improve the country’s ability to carry out surveys and surveillance for HIV, tuberculosis (TB), sexually transmitted infections (STIs), and other diseases that matter for public health. In practical terms, the announcement is about building stronger national capacity to generate reliable data (strategic information) and to use that data to guide and manage the national HIV/AIDS response, while also ensuring the laboratory backbone exists to support surveillance and day-to-day clinical and public health needs. The emphasis on "integrated" systems signals that the work is not meant to be siloed by disease, but rather coordinated across HIV, TB, STIs, and other priority conditions, reflecting how laboratory networks, specimen referral, quality systems, and surveillance platforms often serve multiple programs at once.
A key set of priorities highlighted in the eligibility information is expanding and strengthening HIV/STD/TB surveillance programs and improving national capacity to collect, manage, and use HIV-related surveillance data. This includes the kinds of systems that allow a country to understand where infections are occurring, which populations are most affected, how trends change over time, and whether prevention and treatment efforts are working. Alongside the data side, the FOA underscores the need for stronger laboratory support for surveillance, diagnosis, treatment, and disease monitoring. This implies activities such as improving laboratory quality management, ensuring testing services are accurate and reliable, strengthening workflows and infrastructure that allow timely and safe specimen handling, and reinforcing the broader laboratory network needed to support national programs.
The laboratory strengthening component is also explicitly tied to HIV screening for blood safety, which is a critical element of national HIV prevention. By calling out blood safety, the FOA indicates support for the laboratory capacity and systems required to screen blood and blood products effectively, reducing transfusion-related HIV transmission risks. More broadly, the opportunity frames laboratory systems as foundational not only for diagnosing individuals but also for monitoring disease, evaluating program performance, and supporting national public health decision-making.
The CDC structured the mechanism as a cooperative agreement rather than a simple grant, which generally means the funder expects substantial involvement in program implementation and technical direction. In a public health systems strengthening award like this, that often translates into close collaboration with CDC on planning, technical standards, performance monitoring, and alignment with PEPFAR priorities and reporting expectations. The title’s reference to "technical leadership" also signals an intent to build or reinforce national leadership and coordination capacity, not just to procure equipment or run isolated trainings.
Eligibility is described as "Others (see text field entitled Additional Information on Eligibility for clarification)," but the announcement text makes clear that Ethiopia’s national public health institute at the time, EHNRI, is identified as the governmental agency with the mandate and authority to carry out these public health functions and is described as the only public health agency in Ethiopia with the mandate to do so. This framing indicates the FOA was designed around supporting the nationally mandated institution responsible for these activities, reflecting a focus on building sustainable national systems through the primary government technical body rather than distributing funds broadly across multiple unrelated entities.
Administrative details include an award floor of $0 (meaning no minimum was specified), an award ceiling of $4,000,000, and a single expected award, with the total estimated funding across the program period listed as $20,000,000. The funding instrument type is a cooperative agreement, and the agency is the Centers for Disease Control and Prevention. For applicants needing help accessing the full announcement, the CDC Procurement and Grants Office Technical Information Management office was listed as the contact point, reachable by phone at (770) 488-2700 or by email at pgotim@cdc.gov.
Funding Opportunity FAQs (CDC RFA GH13-1313)
What is the official title of this funding opportunity?
The opportunity is officially titled "Strengthening Capacity for Laboratory Systems, Strategic Information, and Technical Leadership in Public Health for the National HIV/AIDS Response in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR)."
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH13-1313.
Who is the issuing agency?
The issuing agency is the Centers for Disease Control and Prevention (CDC).
What program is this opportunity associated with?
This cooperative agreement is issued under PEPFAR (the Presidents Emergency Plan for AIDS Relief).
What country is the work focused on?
The opportunity is focused on Ethiopia, specifically supporting the national HIV/AIDS response in the Federal Democratic Republic of Ethiopia.
What is the main purpose of this opportunity?
The central purpose is to strengthen Ethiopia's integrated public health laboratory systems and improve the country's ability to carry out surveys and surveillance for HIV, tuberculosis (TB), sexually transmitted infections (STIs), and other public health priority diseases. It also emphasizes strengthening national capacity to generate reliable strategic information and use it to guide and manage the national HIV/AIDS response.
What does "integrated" public health laboratory systems mean in this announcement?
"Integrated" signals that the work is intended to be coordinated across HIV, TB, STIs, and other priority conditions rather than being siloed by disease. In practice, this reflects that laboratory networks, specimen referral, quality systems, and surveillance platforms can serve multiple programs at once.
What activity category does this opportunity fall under?
This opportunity sits within the health activity category.
What is the CFDA number and program name associated with this opportunity?
The opportunity is listed under CFDA 93.067 (Global AIDS).
What type of funding mechanism is being used?
The mechanism is a cooperative agreement.
What does it mean that this is a cooperative agreement (instead of a standard grant)?
A cooperative agreement generally means CDC expects substantial involvement in implementation and technical direction. In this context, that can include close collaboration with CDC on planning, technical standards, performance monitoring, and alignment with PEPFAR priorities and reporting expectations.
How many awards did CDC anticipate making under this announcement?
CDC anticipated making one award under this announcement.
What is the estimated total funding amount for this opportunity?
The estimated total funding amount is $20,000,000 (as listed across the program period in the opportunity information provided).
What is the award ceiling?
The award ceiling is $4,000,000.
What is the award floor?
The award floor is listed as $0, meaning no minimum award amount was specified.
Is cost sharing or matching required?
No cost sharing or matching requirement was stated in the provided information.
When was this opportunity posted?
The opportunity was posted on January 29, 2013.
What was the application closing date?
The application closing date was April 15, 2013.
What are the key priority areas highlighted for the work?
The announcement highlights priorities such as expanding and strengthening HIV/STD/TB surveillance programs, improving national capacity to collect, manage, and use HIV-related surveillance data (strategic information), and strengthening laboratory support for surveillance, diagnosis, treatment, and disease monitoring.
What kinds of outcomes are implied by the "strategic information" emphasis?
The emphasis implies building national capacity to generate reliable data and use it to guide decisions for the national HIV/AIDS response, including understanding where infections are occurring, which populations are most affected, how trends change over time, and whether prevention and treatment efforts are working.
How does laboratory strengthening relate to the national HIV/AIDS response in this opportunity?
The opportunity frames laboratory systems as foundational for surveillance and day-to-day clinical and public health needs, including accurate diagnosis, disease monitoring, and evaluating program performance to support national public health decision-making.
Does the opportunity include a focus on blood safety?
Yes. The laboratory strengthening component is explicitly tied to HIV screening for blood safety, supporting the capacity and systems needed to screen blood and blood products effectively and reduce transfusion-related HIV transmission risks.
What diseases and public health areas are specifically mentioned?
The announcement specifically mentions HIV, tuberculosis (TB), sexually transmitted infections (STIs), and other diseases of public health importance, with a strong focus on surveillance and laboratory systems that support these areas.
Who is eligible to apply based on the information provided?
Eligibility is described as "Others (see text field entitled Additional Information on Eligibility for clarification)." The provided announcement text indicates Ethiopia's national public health institute at the time, EHNRI, is identified as the governmental agency with the mandate and authority to carry out these public health functions and is described as the only public health agency in Ethiopia with the mandate to do so.
Does the eligibility description suggest the opportunity was broadly open to many organizations?
Based on the provided information, the eligibility framing indicates the opportunity was designed around supporting the nationally mandated institution responsible for these activities (identified as EHNRI), rather than distributing funds broadly across multiple unrelated entities.
What does "technical leadership" mean in the context of this opportunity?
The reference to technical leadership signals an intent to build or reinforce national leadership and coordination capacity, not only to support equipment purchases or isolated trainings. It aligns with strengthening sustainable national systems through the primary government technical body.
Who can be contacted for help accessing the full announcement?
The CDC Procurement and Grants Office Technical Information Management (PGO TIM) office was listed as the contact point.
What are the contact details provided for the CDC PGO TIM office?
Phone: (770) 488-2700
Email: pgotim@cdc.gov
Browse more business programs for HIV and AIDS support
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Open Competition for Professional Fellows Program
Previous opportunity: Office of Elementary and Secondary Education (OESE) Office of Indian Education (OIE) Indian Education Formula Grants to Local Educational Agencies CFDA Number 84.060A
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1313
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1313) also looked into and applied for these:
| Funding Opportunity |
|---|
| Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief Apply for CDC RGA GH13 1316 Funding Number: CDC RGA GH13 1316 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Clinical Sites for an Undiagnosed Diseases Network (UDN) (U01) Apply for RFA RM 13 004 Funding Number: RFA RM 13 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementation of Integrated HIV/AIDS Treatment, Care and Prevention Programs in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1316 Funding Number: CDC RFA GH13 1316 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Strengthening Community Care and Support Systems and Services (SCCSSS) in Namibia Apply for SOL 673 13 000002 Funding Number: SOL 673 13 000002 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $9,000,000 |
| Indigenous Child Health Strong Communities, Healthy Children Apply for HHS 2013 IHS HPDP 0001 Funding Number: HHS 2013 IHS HPDP 0001 Agency: Indian Health Service Category: Health Funding Amount: $100,000 |
| Providing Information System Support for Training and Implementation of National HIV Monitoring Systems in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief Apply for CDC RFA GH13 1318 Funding Number: CDC RFA GH13 1318 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $320,000 |
| NIA Limited Competition Renewals of, and Revisions to, Existing Cooperative agreement Awards (U01) Apply for PAR 13 097 Funding Number: PAR 13 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Behavioral and Serological Survey (BSS) for HIV and Syphilis among Diamond Mine Workers in Angola Apply for CDC RFA GH13 1354 Funding Number: CDC RFA GH13 1354 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Technical Collaboration with the Peoples Republic of China (PRC) on Innovative Approaches to Increase the Effectiveness of the HIV/AIDS Response in China and Globally under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1364 Funding Number: CDC RFA GH13 1364 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Disorders of Human Communication Effectiveness, Outcomes and Health Services Research (R21) Apply for PA 13 103 Funding Number: PA 13 103 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Disorders of Human Communication Effectiveness, Outcomes and Health Services Research (R01) Apply for PA 13 102 Funding Number: PA 13 102 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High End Instrumentation Grant Program (S10) Apply for PAR 13 101 Funding Number: PAR 13 101 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Limited Competition Global Health Research and Research Training eCapacity Initiative (R25) Apply for PAR 13 107 Funding Number: PAR 13 107 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| APS for Microbicide Research, Development, and Introduction, Round 2 Apply for APS OAA 13 000001 Funding Number: APS OAA 13 000001 Agency: Agency for International Development Category: Health Funding Amount: $168,000,000 |
| Affordable Care Act Health Center Controlled Networks Apply for HRSA 13 267 Funding Number: HRSA 13 267 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Maternal and Child Health (MCH) Nutrition Training Program Apply for HRSA 13 180 Funding Number: HRSA 13 180 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Genomic Centers for Infectious Diseases (U19) Apply for RFA AI 13 009 Funding Number: RFA AI 13 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| MCH Knowledge to Practice Program Apply for HRSA 13 197 Funding Number: HRSA 13 197 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Dental Reimbursement Program Apply for HRSA 13 171 Funding Number: HRSA 13 171 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| MCH Navigator Program Apply for HRSA 13 262 Funding Number: HRSA 13 262 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1313", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.